Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Introduction Suicidal behavior is strongly associated with depression in major depressive (MDD) and bipolar (BD) disorders, especially with associated behavioral activation, dysphoria, or agitation. A rare intervention with evidence of suicide risk-reducing as well as mood-stabilizing effects in mood disorder patients is lithium. Methods We reviewed available research evidence on associations of long-term treatment with lithium with risk of suicidal behavior. We meta-analyzed 12 randomized trials in 10 reports (with at least 1 suicide in either treatment arm) including both BD and MDD subjects, with particular attention to comparisons of lithium with placebo or other pharmacological treatments. We also summarized ecological studies on lithium concentration in local drinking water and reported suicide rates. Results We found substantial reduction of risks of suicide and attempts with long-term lithium treatment, particularly in depressive phases of BD and in MDD. Risk of suicidal behavior was higher in mixed (agitated-dysphoric) states than in manic or hypomanic periods. Risk of suicide fatality, specifically, was lower with lithium than with placebo and probably with mood-altering anticonvulsants or antidepressants. Discussion Long-term treatment with lithium has growing evidence of suicide- and attempt-sparing effects, probably greater than with anticonvulsants or antidepressants; antipsychotics remain to be tested adequately. However, the ethical and scientifically adequate design and conduct of trials of treatments aimed at suicide prevention remain challenging and underdeveloped.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“The standardized mortality ratio for suicide in clinical groups versus the comparable general population is highest in mood disorders, usually at 10–20-fold [7].”
BackgroundMeltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 3×
“Indeed, only 1 treatment—the highly effective antipsychotic drug clozapine—has regulatory recognition for ability to reduce suicidal risk, and only for patients diagnosed with schizophrenia [4, 5].”
BackgroundResultTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920 · cited 2×
“Data are derived from previous reviews [35, 36].”
MethodPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770 · cited 3×
“However, antidepressant treatment is not explicitly approved for use in bipolar depression and may not be effective or safe long-term in BD, in which its prophylactic value versus destabilizing risks remains insufficiently studied [19, 94, 95].”
BackgroundResultSelf-citationDecreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Self-citationPrien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448 · cited 3×
“Prien et al. 1973 [46]; MAD, PBO Calabrese et al. 2003 [40]; BD, LTG Lauterbach et al. 2008 [44]; MDD, PBO Licht et al. 2010 [45]; BD, LTG 0.00 0.01 0.10 1.00 10.0 Odds Ratio [95 %CI] [0.10 – 0.50]; p < 0.0001 favors lithium nullPooled OR = 0.22 Tohen et al. 2005 [48]; BD, ONZ Bauer et al. 2000…”
InfluentialJakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366 · cited 1×
“Evidence for short- and long-term efficacy of antidepressant treatment in unipolar MDD is substantial [13, 19, 87–93] but not universally accepted [93].”
BackgroundBaldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Self-citationLithium and suicide in mood disorders: Updated meta‐review of the scientific literature
Smith, K. A., & Cipriani, A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12543 · Cited by 247
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
Self-citationAntipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208
Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders
Forte, A., Baldessarini, R. J., Tondo, L., Vázquez, G. H., Pompili, M., & Girardi, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.02.011 · Cited by 203
Self-citationSchaffer, A., Isometsä, E. T., Tondo, L., Moreno, D. H., Sinyor, M., Kessing, L. V., Turecki, G., Weizman, A., Azorin, J.-M., Ha, K., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415594427 · Cited by 175 · cited 1×
“0–324), and in 7 studies the rate was 366 in men and 217 in women [8].”
BackgroundSelf-citationGibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., & Mann, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1044 · Cited by 167
Oquendo, M. A., Galfalvy, H. C., Currier, D., Grunebaum, M. F., Sher, L., Sullivan, G. M., Burke, A. K., Harkavy-Friedman, J., Sublette, M. E., Parsey, R. V., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010163 · Cited by 165
Relationship Between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder
Gibbons, R. D., Hur, K., Brown, C. H., & Mann, J. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.159 · Cited by 156
Lauterbach, E., Felber, W., Müller‐Oerlinghausen, B., Ahrens, B., Bronisch, T., Meyer, T., Kilb, B., Lewitzka, U., Hawellek, B., Quante, A., et al. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01266.x · Cited by 154 · cited 6×
“…14 0.00 1 14 6.67 MDD 20 ≥ 18 0.75 PBO Calabrese et al. 2003 0 121 0.00 1 220 0.45 BD 78 ≥ 18 0.58 LTG Tohen et al. 2005 1 213 0.47 0 217 0.00 BD 52 ≥ 18 0.75 ONZ Lauterbach et al. 2008 0 84 0.00 3 80 3.61 MDD 52 ≥ 18 0.70 PBO Licht et al. 2010 1 77 1.28 0 77 0.00 BD 52 ≥ 18 0.90 LTG Weighted…”
InfluentialSuicide attempts in bipolar disorders: comprehensive review of 101 reports
Tondo, L., Pompili, M., Forte, A., & Baldessarini, R. J. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12517 · Cited by 132 · cited 2×
“40-fold higher among women than men [9].”
ResultSelf-citationSelle, V., Schalkwijk, S., Vázquez, G., & Baldessarini, R. (2014) · Pharmacopsychiatry · doi:10.1055/s-0033-1363258 · Cited by 128
Self-citationHayes, J. F., Pitman, A., Marston, L., Walters, K., Geddes, J. R., King, M., & Osborn, D. P. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0432 · Cited by 121
El-Mallakh, R. S., Vöhringer, P. A., Ostacher, M. M., Baldassano, C. F., Holtzman, N. S., Whitham, E. A., Thommi, S. B., Goodwin, F. K., & Ghaemi, S. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.054 · Cited by 120 · cited 1×
“Antidepressant response in BD may be better among patients without agitated-dysphoric forms of depression or mixed features [95] and without previous rapidcycling [97].”
BackgroundHayes, J. F., Marston, L., Walters, K., Geddes, J. R., King, M., & Osborn, D. P. J. (2016) · World Psychiatry · doi:10.1002/wps.20298 · Cited by 115
Braun, C., Bschor, T., Franklin, J., & Baethge, C. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442293 · Cited by 103 · cited 1×
“Additional studies involving mainly retrospective observations of large cohorts of depressed patients and case-control comparisons have yielded inconsistent and inconclusive findings [19, 100, 102].”
ResultDe Dios, C., Ezquiaga, E., Garcia, A., Soler, B., & Vieta, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.006 · Cited by 56
Cited by
Suicide Risk in Bipolar Disorder: A Brief Review
Dome, P., Rihmer, Z., & Gonda, X. (2019) · Medicina · doi:10.3390/medicina55080403 · Cited by 269
Bipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
Self-citationLithium and suicide prevention in mood disorders and in the general population: A systematic review
Del Matto, L., Muscas, M., Murru, A., Verdolini, N., Anmella, G., Fico, G., Corponi, F., Carvalho, A. F., Samalin, L., Carpiniello, B., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.017 · Cited by 120
Averill, L. A., Averill, C. L., Gueorguieva, R., Fouda, S., Sherif, M., Ahn, K.-H., Ranganathan, M., D'Souza, D. C., Southwick, S. M., Sanacora, G., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.104 · Cited by 33
Pharmacologic approaches to suicide prevention
Zisook, S., Domingues, I., & Compton, J. (2023) · Focus · doi:10.1176/appi.focus.20220076 · Cited by 30
Metadata
- Authors
- Tondo, L., & Baldessarini, R.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2018-04-19
- Volume
- 51
- Issue
- 05
- Pages
- 177-188
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2800064120
- Cited by
- 69
- References
- 27
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.